Lack of effect of sumatriptan and UK‐14,304 on capsaicin‐induced relaxation of guinea‐pig isolated basilar artery
Open Access
- 1 January 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 108 (1) , 191-195
- https://doi.org/10.1111/j.1476-5381.1993.tb13461.x
Abstract
1 The objectives of this study were to assess the effects of sensory neuropeptide antagonists and presynaptically acting receptor agonists on capsaicin-induced relaxations of guinea-pig isolated basilar artery (GPBA). 2 Capsaicin, human α-calcitonin gene-related peptide (CGRP) and substance P (SP) caused concentration-related relaxations of GPBA which had been pre-contracted with prostaglandin F2α (PGF2α). Responses to capsaicin were not modified by the peptidase inhibitors, phosphoramidon (1 μm) and bestatin (100 μm). 3 The relaxant responses to capsaicin were blocked in a selective manner by ruthenium red (3 μm) and by the CGRP antagonist, CGRP8_37 (1 μm). CGRP8_37 also selectively inhibited the relaxant effects of CGRP. 4 The selective NK1 receptor antagonist, GR82334 (10 μm), inhibited SP-induced relaxations but had little effect on capsaicin-induced relaxations. 5 The 5-HT1 receptor agonist, sumatriptan, produced small contractions of GPBA under conditions of resting tone. In the presence of PGF2α, sumatriptan had no further contractile effect. Sumatriptan (0.3 and 3 μm) did not modify capsaicin-induced relaxations of GPBA. 6 The α2-adrenoceptor agonist, UK-14,304 (0.1 μm), had no effect on basal or PGF2α-induced tone. UK-14,304 did not modify capsaicin-induced relaxations. 7 These results suggest that capsaicin causes relaxation of GPBA via a release of CGRP. This process is amenable to blockade by CGRP8–37 and ruthenium red, but not to modulation by either sumatriptan or UK-14,304.Keywords
This publication has 32 references indexed in Scilit:
- Mode of action of the anti-migraine drug sumatriptanTrends in Pharmacological Sciences, 1991
- Treatment of Migraine Attacks with SumatriptanNew England Journal of Medicine, 1991
- Tachykinins (Substance P, Neurokinin A, Neuropeptide K, and Neurokinin B) in the Cerebral Circulation: Vasomotor Responses in vitro and in situJournal of Cerebral Blood Flow & Metabolism, 1991
- Human α-calcitonin gene-related peptide-(8–37) as an antagonist of exogenous and endogenous calcitonin gene-related peptideEuropean Journal of Pharmacology, 1991
- Opioid receptors and prejunctional modulation of capsaicin-sensitive sensory nerves in guinea-pig left atriumGeneral Pharmacology: The Vascular System, 1990
- Modulatory action of galanin on responses due to antidromic activation of peripheral terminals of capsaicin-sensitive sensory nervesEuropean Journal of Pharmacology, 1989
- The antagonism induced by Ruthenium Red of the actions of capsaicin on the peripheral terminals of sensory neurons: further studiesEuropean Journal of Pharmacology, 1988
- Pharmacological receptors for substance P and neurokininsLife Sciences, 1987
- Binding of Lanthanum Ions and Ruthenium Red to Synaptosomes and Its Effects on Neurotransmitter ReleaseJournal of Neurochemistry, 1985
- UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypesEuropean Journal of Pharmacology, 1981